CROCI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 535
EU - Europa 464
AS - Asia 154
SA - Sud America 32
AF - Africa 3
Totale 1.188
Nazione #
US - Stati Uniti d'America 528
GB - Regno Unito 168
RU - Federazione Russa 111
IE - Irlanda 62
CN - Cina 54
SG - Singapore 39
BR - Brasile 29
UA - Ucraina 25
VN - Vietnam 23
SE - Svezia 22
IT - Italia 17
DE - Germania 15
FR - Francia 13
FI - Finlandia 12
HK - Hong Kong 10
TR - Turchia 9
ES - Italia 6
CA - Canada 5
IN - India 5
AR - Argentina 3
BD - Bangladesh 3
BE - Belgio 3
LT - Lituania 3
PK - Pakistan 3
PL - Polonia 3
SA - Arabia Saudita 3
AT - Austria 2
ZA - Sudafrica 2
AL - Albania 1
BH - Bahrain 1
CI - Costa d'Avorio 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
NO - Norvegia 1
PA - Panama 1
TT - Trinidad e Tobago 1
Totale 1.188
Città #
Southend 157
Dallas 81
Dublin 59
Fairfield 56
Ashburn 50
Chandler 39
Moscow 35
Seattle 24
Menlo Park 23
Singapore 23
Santa Clara 20
Wilmington 20
Woodbridge 20
Jacksonville 19
Beijing 18
Dong Ket 18
Cambridge 17
Ann Arbor 16
Houston 12
Munich 11
Hong Kong 10
New York 10
Dearborn 9
Siena 9
Helsinki 8
Izmir 8
Princeton 8
Los Angeles 6
Fremont 5
Málaga 4
Phoenix 4
Shanghai 4
Shenyang 4
Turku 4
Boardman 3
Brussels 3
Columbus 3
Hebei 3
San Diego 3
The Dalles 3
Atlanta 2
Council Bluffs 2
Florence 2
Hefei 2
Islamabad 2
Jinan 2
Johannesburg 2
Loma Hermosa 2
London 2
Nanchang 2
Nuremberg 2
Orem 2
Porto Alegre 2
San Mateo 2
Sezze 2
Stockholm 2
Tianjin 2
Toronto 2
Vienna 2
Warsaw 2
Abidjan 1
Ankara 1
Aracaju 1
Araraquara 1
Bangalore 1
Bauru 1
Belo Horizonte 1
Boston 1
Brasília 1
Brooklyn 1
Buffalo 1
Bến Lức 1
Caxias do Sul 1
Changsha 1
Charqueadas 1
Chennai 1
Chicago 1
Dammam 1
Denver 1
Dhaka 1
Düsseldorf 1
Edinburgh 1
Evans 1
Falkenstein 1
Fortaleza 1
Frederico Westphalen 1
Fuzhou 1
Guangzhou 1
Guarabira 1
Guarulhos 1
Haiphong 1
Hamad Town 1
Hangzhou 1
Hanoi 1
Ho Chi Minh City 1
Hounslow 1
Ipiaú 1
Itu 1
Jardinópolis 1
Jeddah 1
Totale 909
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 363
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 329
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 280
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 234
Totale 1.206
Categoria #
all - tutte 3.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 16 2 18 10 9 4 26
2021/202277 5 13 5 1 7 1 6 6 6 6 7 14
2022/2023104 4 13 15 17 12 15 1 8 7 6 4 2
2023/202498 1 1 6 4 1 31 47 0 2 0 0 5
2024/2025127 6 7 19 7 14 5 7 9 2 6 19 26
2025/2026323 27 49 65 67 112 3 0 0 0 0 0 0
Totale 1.206